EXAS vs TRINI
EXACT Sciences Corporation (EXAS) versus Trinity Capital Inc. 7.875% Notes Due 2029 (TRINI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Trinity Capital Inc. 7.875% Notes Due 2029 (TRINI) common stock listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
TRINI does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. TRINI currently screens at market cap $0.
Not investment advice. Open the EXAS and TRINI stock pages for the full models.
Not investment advice.